Mineralys Therapeutics, Inc.'s total assets for Q3 2024 were $268.25M, a decrease of -15.77% from the previous quarter. MLYS total liabilities were $31.32M for the fiscal quarter, a 10.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.